The research team, led by Sampurna Nivedita Sarkar of D.Y. Patil International University in Pune and Abhi Mallick of Vidyasagar University in Midnapore, together with colleagues from Kolkata institutions, subjected the isolate to a battery of tests that combined classical microbiology with whole-genome sequencing. Identification and antimicrobial susceptibility testing followed Clinical and Laboratory Standards Institute guidelines, and the team also assessed whether the strain displayed hypermucoviscosity, the stringy, overproduced-capsule phenotype often associated with hypervirulent klebsiellae. The genome itself, assembled to a total size of 5.47 megabases, resolved into a 5.2-megabase chromosome and three plasmid-associated contigs predicted by the MOB-suite toolset, carrying replicon types IncFIIK, IncHI1B/IncFIB, and IncR. That plasmid complement is significant in its own right, because these mobile elements are the vehicles by which resistance genes travel between bacterial lineages, turning isolated incidents into sustained outbreaks.

Sequence typing placed the isolate in ST709, which the authors describe as a single-locus variant of ST15. This detail carries considerable epidemiological weight. ST15 is recognized internationally as a high-risk clone of K. pneumoniae, a lineage that has successfully disseminated across hospitals and continents while accumulating resistance determinants. A single-locus variant means the Indian strain differs from the canonical ST15 profile at just one of the seven housekeeping genes used in multilocus sequence typing, placing it firmly within that successful genetic background. The capsular typing added another layer of identity: KL9, paired with the O2 antigen locus. Capsular type matters clinically because the polysaccharide capsule is a bacterium’s primary shield against immune attack, and specific K loci have been linked to particular virulence and transmission behaviors in global clone surveys.

The susceptibility results painted the picture of a genuinely multidrug-resistant organism. The strain resisted ceftriaxone, a third-generation cephalosporin that forms a backbone of neonatal sepsis empiric therapy in many Indian hospitals; ciprofloxacin, a fluoroquinolone; chloramphenicol, an older agent still used in resource-limited settings; and co-trimoxazole, the sulfonamide combination. Only three agents remained effective in testing: meropenem, a carbapenem representing one of the last widely available oral-infusion classes before the deepest reserve drugs; amikacin, an aminoglycoside; and colistin, the polymyxin often described as the antibiotic of last resort. For a newborn, whose kidneys and nervous systems tolerate drugs differently from adults, that narrowing list of options is not an abstraction. It translates directly into longer intensive care stays, more toxic exposures, and higher mortality risk.

Sequencing explained the phenotype with unusual completeness. The resistome included blaTEM-1B and blaCTX-M-15, the latter being the enzyme that hydrolyzes third-generation cephalosporins and defines much of the extended-spectrum beta-lactamase problem across Asia. Alongside these sat qnrS1, which reduces fluoroquinolone susceptibility; strA and strB, which inactivate streptomycin; catA1, which acetylates chloramphenicol; sul1 and sul2, which bypass sulfonamide inhibition of folate synthesis; dfrA1 and dfrA5, which do the same for trimethoprim; fosA6, which detoxifies fosfomycin; and the tetracycline efflux and protection genes tetA and tetD. The chromosomal complement of point mutations filled in the gaps left by acquired genes. Substitutions at Ser83 and Asp87 in gyrase subunit gyrA, together with Ser80Ile in topoisomerase subunit parC, constitute the classic stepwise mutations that push quinolone resistance to clinically meaningful levels, explaining the ciprofloxacin result even before qnrS1 is considered.

One chromosomal change deserves particular attention: the double substitution Ile70Met and Ile128Met in ompK37, a gene encoding an outer membrane porin. Porins are the channels through which antibiotics, including beta-lactams and carbapenems, must pass to reach their intracellular targets. Reduced expression or altered function of major porins such as OmpK36 and OmpK37 is a well-documented route by which K. pneumoniae raises its intrinsic resistance ceiling, and porin loss frequently cooperates with beta-lactamases to produce carbapenem resistance. In this isolate, the porin mutation did not abolish meropenem susceptibility, but its presence in a strain already carrying blaCTX-M-15 illustrates how the components of future treatment failure assemble incrementally within a single genome. Surveillance that reads whole genomes can catch this assembly in progress, long before a clinician encounters a truly untreatable isolate.

The virulence analysis told a more nuanced story than the resistance picture. The strain carried type 1 and type 3 fimbriae, the hair-like appendages that mediate adhesion to epithelial and abiotic surfaces and are central to biofilm formation on catheters and endotracheal tubes in neonatal units. It harbored a complete type VI secretion system cluster of the first isoform, a molecular spear gun that bacteria use to kill competing microbes and to manipulate host cells, and the full KL9 capsule biosynthesis locus. It also possessed the enterobactin siderophore system, the iron-scavenging machinery that is baseline equipment for enteric bacteria in the iron-starved environment of the human body. Yet, critically, the genome lacked the canonical markers of hypervirulent K. pneumoniae: iucA of the aerobactin system, the ybt yersiniabactin cluster, rmpA and rmpA2 regulators of hypermucoviscosity, iroB of the salmochelin system, and peg344. The strain was not phenotypically hypermucoviscous either.

This absence is scientifically telling. A long-standing debate in klebsiella biology concerns whether resistance and virulence travel together or trade off against each other, and several recent genomic surveys have described an inverse relationship between the resistome and the virulome, suggesting that carrying heavy plasmid loads of resistance genes imposes a metabolic cost that discourages the acquisition of hypervirulence plasmids. The West Bengal isolate fits that pattern: a classical, non-hypervirulent genetic background, but one loaded with resistance machinery and belonging to a high-risk clone. The concern is convergence. When a high-risk, drug-resistant lineage such as ST15 acquires even the modest virulence toolkit seen here, and when plasmids carrying blaCTX-M-15 circulate freely among strains, the evolutionary distance to a genuinely hypervirulent, extensively resistant organism shrinks. Reports from China, Egypt, and elsewhere have already documented such convergence events, making each new resistant clone report a piece of a global early-warning puzzle.

The Indian context sharpens the urgency. Neonatal sepsis is a leading cause of infant mortality in the country, and K. pneumoniae is among the predominant organisms recovered from neonatal blood cultures, with documented outbreaks in neonatal intensive care units and a growing share of carbapenem-resistant and hypervirulent isolates described in the literature. Previous studies have traced CTX-M-15-producing K. pneumoniae across Asian hospitals for well over a decade, noting diverse clones and clonal dissemination, and ST709 itself has appeared in surprising settings, including a commercial chicken farm in China where isolates carried mobile colistin resistance and carbapenemase genes. The appearance of an ST709-KL9 strain in a newborn’s bloodstream in eastern India suggests that this lineage is circulating in the region’s microbial ecosystem, and the authors argue that systematic, strategically designed, large-scale genomic surveillance is essential to understand how such strains traffic between hospitals, communities, and possibly animal reservoirs, and to contain their transmission before resistance options narrow further.

For now, the infant isolate remained treatable with meropenem, amikacin, and colistin, and the study, funded by the Indian Council of Medical Research and Vidyasagar University, stands as a demonstration of what single-isolate genomics can accomplish. From one blood culture, the team extracted a complete identity card: clone, capsule, plasmid complement, resistance genes, resistance mutations, virulence profile, and the telling absences that place the strain within the global population structure of a critical-priority pathogen. The lesson for public health is that such identity cards should not be drawn one at a time, in response to individual alarming cases. They should be drawn routinely, across networks of hospitals, so that the movement of high-risk clones and their plasmids can be tracked in real time. The ten-day-old patient in West Bengal recovered under a narrowing umbrella of last-line drugs; the genome that pathogen carried is a message about how much narrower that umbrella could become.

Subject of Research: Genomic characterization of a multidrug-resistant CTX-M-15-producing Klebsiella pneumoniae ST709-KL9 isolate from neonatal bacteraemia in eastern India

Article Title: Genomic characterization of CTX-M-15-producing Klebsiella pneumoniae ST709-KL9 from neonatal bacteraemia in eastern India

Article References: Sarkar, S. N., Mallick, A., Mitra, S., Sarkar, S., & Das, S. (2026). Genomic characterization of CTX-M-15-producing Klebsiella pneumoniae ST709-KL9 from neonatal bacteraemia in eastern India. Molecular Biology Reports, 53(1), Article 1655. https://doi.org/10.1007/s11033-026-12841-4

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12841-4

Keywords: Klebsiella pneumoniae, ST709, CTX-M-15, antimicrobial resistance, neonatal sepsis, whole-genome sequencing, virulome, resistome, high-risk clone, ST15, plasmids, India